National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

tetradecanoylphorbol acetate
A phorbol ester with potential antineoplastic effects. Tetradecanoylphorbol acetate (TPA) induces maturation and differentiation of hematopoietic cell lines, including leukemic cells. This agent may induce gene expression and protein kinase C (PKC) activity. In addition to potential antineoplastic effects, TPA may exhibit tumor promoting activity. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:Lonomycin
Phorbol Myristate Acetate
Abbreviations:PMA
TPA
Chemical structure name:12-O-tetradecanoylphorbol-13-acetate



Previous:tetanus peptide melanoma vaccine, tetanus toxoid, tetanus toxoid helper peptide, tetracycline antibiotic, tetracycline hydrochloride
Next:tetrahydrouridine, tezacitabine, TGFa-PE38 immunotoxin, thalicarpine, thalidomide

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov